New Vircell COVID-19 Serology Assays

Last updated: 23rd July, 2020

Products are for professional/laboratory use only.  Abacus dx is pleased to announce the launch of two new ELISA kits for the diagnosis of COVID-19 as well as two monotest kits for VirClia systems.

Serology allows confirmation of infection in symptomatic and asymptomatic patients.

Reference Description Kit Contents Insert Sheet
G1032 COVID-19 ELISA IgG 96 tests View here >
MA1032 COVID-19 ELISA IgM+IgA 96 tests View here >
VCM097 COVID-19 VIRCLIA IgG MONOTEST 24 tests View here >
VCM098 COVID-19 VIRCLIA IgM+IgA MONOTEST 24 tests View here >


Main features of Vircell COVID-19 serology assays

  • The use of SARS-CoV-2 recombinant antigens improves the performance of the kits.
  • IgM + IgA detection complements molecular tests when the viral load decreases or when false negatives are suspected due to unsuitable samples in patients with clear symptoms.
  • The combination of IgM + IgA significantly improves sensitivity since COVID-19 affects the mucous membrane. The early production of IgA antibodies in this kind of infections could be particularly high.
  • IgG detection allows monitoring and confirming recovery and possible immunity, when other molecular and serological markers become negative.


Please check regulatory status in your country.

Find out more about Vircell COVID-19 ELISA Tests

View Flyer >

VirClia - Widest Panel for Infectious Serology - Australia

Download Brochure >

VirClia - Widest Panel for Infectious Serology - New Zealand

Download Brochure >

Contact us to find out more about Vircell VirClia

Contact Us Now >

Request a Quote

Request Quote

Go BackGo Back